Non-Disclosure Agreements (NDAs)

 Agreements that protect confidential study-related or proprietary information shared between parties before or during a clinical trial. They help safeguard sensitive data while allowing open discussions for potential collaboration 

  Reduce the need for separate NDAs, streamline recurring collaborations, and ensure consistent protection of information.

  CTAs outline the legal, financial, and operational obligations between the sponsor and the research site. They address scope of work, responsibilities, and payment terms.

  Overarching agreements that define the general terms and conditions for ongoing collaborations between a sponsor and a site or vendor. They streamline future contract negotiations by reducing redundancy.

  Modifications or additions to existing agreements that reflect protocol changes, budget adjustments, or updated regulatory requirements.